Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

UCB Group buys 51% of Meizler Biopharma

Executive Summary

UCB Group has acquired 51% of Brazilian pharmaco Meizler Biopharma SA. UCB will provide payments that include performance-based milestones, and it has the option to buy the remainder of the company.
Deal Industry
  • Pharmaceuticals
    • Specialty Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Acquisition
    • Partial Acquisition
    • Includes Earnout

Related Companies

Advertisement
UsernamePublicRestriction

Register